Table 1 Patient sample description
From: A pilot open-label trial of minocycline in patients with autism and regressive features
Subject | Pretreatment age (months) | Sex | Age at onset of regression (months) | Clinical assessment | ||||
|---|---|---|---|---|---|---|---|---|
Non-verbal IQ/DQ | CGI- baseline | CGI- post-treatment | Vineland- ABC baseline | Vineland-ABC post-treatment | ||||
1 | 99 | F | 27 | 30 | 6 | 5 | 55 | 54 |
2a | 64 | M | 13 | 60 | 5 | 4a | 68 | 73a |
3 | 69 | M | 12 | 33 | 5 | 5 | 45 | 44 |
4 | 153 | M | 19 | 77 | 5 | 5 | 56 | 55 |
5 | 91 | M | 8 | 58 | 3 | 3 | 60 | 56 |
6 | 66 | M | 18 | 103 | 4 | 4 | 70 | 71 |
7 | 128 | F | 15 | 25 | 5 | 5 | 55 | 46 |
8 | 112 | M | 14 | 33 | 5 | 5 | 53 | 56 |
9 | 49 | M | 18 | 59 | 4 | 4 | 66 | 63 |
10 | 38 | M | 22 | 90 | 4 | 3 | 70 | 66 |
11 | 83 | M | 18 | 32 | 5 | 5 | 48 | 57 |
|  |  |  |  | M ± SD | 4.6 ± 0.8 | 4.4 ± 0.8 | 58.7 ± 8.8 | 58.3 ± 9.3 |
|  |  |  |  | Effect Size | - | −0.3 | - | −0.1 |